Human GOLPH2 promoter is active in liver cancer cells, but low in normal liver cells (Figure 1), which makes GOLPH2 promoter a promising candidate for designing HCC-specific oncolytic adenoviruses. Here, GOLM1 is linked to hepatocellular carcinoma.